NeuroMetrix to Exhibit Wearable Device for Widespread Chronic Pain Relief

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.


NeuroMetrix, Inc. (Nasdaq: NURO) will be exhibiting at SLEEP 2017, the 31st Annual Meeting of the Associated Professional Sleep Societies LLC (APSS) June 5-7, 2017 in Boston, MA. SLEEP 2017 is the largest scientific meeting dedicated exclusively to sleep medicine and sleep research.

The company is showing Quell®, its 100% drug-free Wearable Pain Relief Technology™ to sleep medicine professionals from around the world.

“Chronic pain can be extremely disruptive to one’s quality of life,” said Shai N. Gozani, M.D., Ph.D. “Many people find that their pain tends to increase throughout the day and peak at night. Unfortunately, those higher levels of pain can prevent them from getting to sleep and staying asleep. We’re pleased to have an opportunity to show sleep medicine professionals a drug-free pain relief option they can share with their patients.”

Quell measures and tracks sleep data to help users understand the amount and quality of their sleep. Quell also analyzes body movements and position while users are sleeping.



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles